Prospera Financial Services’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.04M Sell
35,440
-2,114
-6% -$121K 0.03% 513
2026
Q1
$2.28M Buy
37,554
+4,231
+13% +$247K 0.04% 464
2025
Q4
$1.8M Sell
33,323
-9,007
-21% -$433K 0.03% 502
2025
Q3
$1.91M Sell
42,330
-11,667
-22% -$545K 0.03% 483
2025
Q2
$2.5M Sell
53,997
-10,360
-16% -$509K 0.05% 405
2025
Q1
$3.93M Buy
64,357
+13,457
+26% +$784K 0.09% 240
2024
Q4
$2.88M Sell
50,900
-22,355
-31% -$1.25M 0.07% 294
2024
Q3
$3.79M Buy
73,255
+20,916
+40% +$981K 0.1% 228
2024
Q2
$2.17M Buy
52,339
+11,692
+29% +$523K 0.06% 318
2024
Q1
$2.21M Buy
40,647
+12,483
+44% +$636K 0.07% 313
2023
Q4
$1.45M Sell
28,164
-3,319
-11% -$174K 0.05% 378
2023
Q3
$1.83M Buy
31,483
+4,100
+15% +$251K 0.07% 283
2023
Q2
$1.75M Buy
27,383
+731
+3% +$49K 0.07% 286
2023
Q1
$1.85M Sell
26,652
-163
-0.6% -$11.5K 0.08% 279
2022
Q4
$1.93M Sell
26,815
-460
-2% -$34.7K 0.1% 235
2022
Q3
$1.94M Buy
27,275
+1,147
+4% +$83.2K 0.1% 235
2022
Q2
$2.01M Buy
26,128
+3,246
+14% +$247K 0.1% 241
2022
Q1
$1.67M Buy
22,882
+362
+2% +$24.3K 0.07% 310
2021
Q4
$1.41M Buy
22,520
+5,903
+36% +$346K 0.06% 335
2021
Q3
$984K Sell
16,617
-7,048
-30% -$464K 0.05% 376
2021
Q2
$1.58M Buy
23,665
+4,784
+25% +$312K 0.08% 281
2021
Q1
$1.19M Sell
18,881
-2,597
-12% -$162K 0.07% 307
2020
Q4
$1.33M Buy
21,478
+8,685
+68% +$534K 0.09% 241
2020
Q3
$771K Sell
12,793
-3,012
-19% -$181K 0.29% 65
2020
Q2
$929K Buy
15,805
+377
+2% +$22.5K 0.08% 242
2020
Q1
$860K Sell
15,428
-6,170
-29% -$377K 0.09% 215
2019
Q4
$1.39M Buy
21,598
+10,008
+86% +$573K 0.11% 218
2019
Q3
$588K Buy
11,590
+718
+7% +$33.7K 0.06% 269
2019
Q2
$495K Buy
+10,872
New +$506K 0.06% 290
2019
Q1
Sell
-40,057
Closed -$2.06M 337
2018
Q4
$2.06M Sell
40,057
-2,751
-6% -$148K 0.42% 47
2018
Q3
$2.58M Sell
42,808
-6,321
-13% -$375K 0.48% 37
2018
Q2
$2.73M Sell
49,129
-35
-0.1% -$1.89K 0.37% 48
2018
Q1
$3.1M Sell
49,164
-2,196
-4% -$141K 0.43% 40
2017
Q4
$3.16M Sell
51,360
-12,966
-20% -$811K 0.48% 34
2017
Q3
$4.14M Sell
64,326
-421
-0.7% -$24.6K 0.63% 17
2017
Q2
$3.59M Sell
64,747
-785
-1% -$42.7K 0.58% 22
2017
Q1
$3.53M Buy
65,532
+15,991
+32% +$877K 0.64% 20
2016
Q4
$2.93M Buy
49,541
+13,377
+37% +$731K 0.57% 30
2016
Q3
$1.95M Buy
36,164
+16,199
+81% +$1.04M 0.39% 48
2016
Q2
$1.47M Buy
19,965
+4,005
+25% +$283K 0.3% 64
2016
Q1
$1.02M Buy
15,960
+2,911
+22% +$184K 0.23% 79
2015
Q4
$898K Sell
13,049
-1,051
-7% -$69.5K 0.2% 79
2015
Q3
$794K Buy
14,100
+973
+7% +$61.7K 0.2% 79
2015
Q2
$827K Buy
13,127
+210
+2% +$13.8K 0.2% 87
2015
Q1
$789K Buy
12,917
+1,732
+15% +$108K 0.18% 83
2014
Q4
$660K Sell
11,185
-1,547
-12% -$87.2K 0.16% 103
2014
Q3
$616K Buy
12,732
+1,027
+9% +$51.3K 0.17% 97
2014
Q2
$568K Buy
11,705
+4,771
+69% +$235K 0.15% 109
2014
Q1
$324K Buy
6,934
+201
+3% +$10.7K 0.1% 155
2013
Q4
$358K Buy
6,733
+96
+1% +$4.89K 0.12% 141
2013
Q3
$314K Sell
6,637
-1,198
-15% -$52.6K 0.12% 148
2013
Q2
$351K Buy
+7,835
New +$340K 0.16% 139

Other funds holding BMY

Prospera Financial Services's BMY Position: Q2 2026 in Review

Prospera Financial Services reduced its Bristol-Myers Squibb (BMY) stake by 5.6% in Q2 2026, selling an estimated $121K and leaving 35,440 shares worth $2.04M. The position accounts for 0.03% of the portfolio, ranked #513.

Prospera Financial Services first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.14M in Q3 2017. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Prospera Financial Services held 35,440 shares of Bristol-Myers Squibb worth $2.04M as of Q2 2026.
  • Prospera Financial Services sold 2,114 Bristol-Myers Squibb shares in Q2 2026, an estimated $121K.
  • Bristol-Myers Squibb made up 0.03% of Prospera Financial Services's portfolio in Q2 2026, its #513 holding.
  • Prospera Financial Services first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Prospera Financial Services's Bristol-Myers Squibb position peaked at $4.14M in Q3 2017.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.